Pages that link to "Q33495419"
Jump to navigation
Jump to search
The following pages link to Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. (Q33495419):
Displaying 50 items.
- Thrombin activation and liver inflammation in advanced hepatitis C virus infection (Q26749460) (← links)
- Occult HCV Infection: The Current State of Knowledge (Q26770595) (← links)
- Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis (Q26773278) (← links)
- Thrombosis Associated with Viral Hepatitis (Q26781784) (← links)
- Immune Components of Liver Damage Associated with Connective Tissue Diseases (Q27015533) (← links)
- Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection (Q27477934) (← links)
- Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection (Q27480668) (← links)
- Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis (Q28082873) (← links)
- Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections (Q28362586) (← links)
- Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids (Q28364192) (← links)
- Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome (Q33331690) (← links)
- Treatment of hepatitis C related thrombocytopenia with interferon alpha (Q33340288) (← links)
- Unusual manifestations of the antiphospholipid syndrome (Q33348373) (← links)
- Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients (Q33378075) (← links)
- Cell damage at the origin of antiphospholipid antibodies and their pathogenic potential in recurrent pregnancy loss (Q33379576) (← links)
- Antiphospholipid antibodies: paradigm in transition (Q33382848) (← links)
- Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection (Q33440130) (← links)
- Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study (Q33443797) (← links)
- Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B. (Q33498803) (← links)
- Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. (Q33698258) (← links)
- Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis (Q33839099) (← links)
- The antiphospholipid syndrome and infection (Q34317744) (← links)
- Origin of antiphospholipid antibodies. (Q34354708) (← links)
- Antiphospholipid antibodies and infections (Q35107007) (← links)
- Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection (Q35548278) (← links)
- Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients (Q35553410) (← links)
- Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis (Q35595386) (← links)
- Rituximab-based treatment, HCV replication, and hepatic flares (Q36167378) (← links)
- Hepatitis C Virus Infection Associated With an Increased Risk of Deep Vein Thrombosis: A Population-Based Cohort Study (Q36255956) (← links)
- Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection (Q36524424) (← links)
- Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview (Q37045158) (← links)
- Review: Viral infections and mechanisms of thrombosis and bleeding (Q38038832) (← links)
- Hepatitis C virus and autoimmunity (Q38497354) (← links)
- Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients (Q40836416) (← links)
- Hepatitis C virus infection and autoimmunity (Q41377154) (← links)
- Anticardiolipin antibodies and hepatic artery thrombosis after liver transplantation (Q41644475) (← links)
- Review: Hepatitis C virus, autoimmunity and rheumatic disease (Q41669589) (← links)
- Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. (Q41930841) (← links)
- Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome (Q42993885) (← links)
- Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection. (Q42997230) (← links)
- Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo (Q43882937) (← links)
- Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin (Q44310007) (← links)
- Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury. (Q44988512) (← links)
- Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies (Q45077755) (← links)
- Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection (Q45418780) (← links)
- Development of lupic anticoagulant during combination therapy in a patient with chronic hepatitis C. (Q50585639) (← links)
- Lymphomes malins et syndrome des antiphospholipides non simultanés : quatre observations (Q58854434) (← links)
- Effectiveness of venous thromboembolism prophylaxis in patients with liver disease (Q64084136) (← links)
- [The etiopathogenic role of hepatitis virus C in the antiphospholipid syndrome] (Q73230125) (← links)
- Anticardiolipin antibodies in hemodialysis patients (Q73314704) (← links)